Pliant Therapeutics, Inc.
- PLRX
- NASDAQ
- Biotechnology
- Fibrosis Therapies
- Clinical-Stage Biotech
$0.90
Today −0.13%Quote Oct 19, 2026, 08:00 PM UTC
−19.04%over the last month
Max drawdown −22.5%From 1-month high −21.2%3 months −17.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Pliant Therapeutics
Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
49
Founded
2015
Market value
$55.6M
Quote Oct 19
Floor
$0.88
1.7% below price
Resistance
$0.94
4.4% above price
Price vs analyst targets
16 analysts
Lowest target
$2.00Highest target
$48.00
$2.00Highest target
$48.00
- Price $0.90
- Average target $25.86
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 2777% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PLRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free